These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1969761)

  • 1. MDMA (ecstasy) effects on cultured serotonergic neurons: evidence for Ca2(+)-dependent toxicity linked to release.
    Azmitia EC; Murphy RB; Whitaker-Azmitia PM
    Brain Res; 1990 Feb; 510(1):97-103. PubMed ID: 1969761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDMA (3,4-methylenedioxymethamphetamine) inhibits the firing of dorsal raphe neurons in brain slices via release of serotonin.
    Sprouse JS; Bradberry CW; Roth RH; Aghajanian GK
    Eur J Pharmacol; 1989 Aug; 167(3):375-83. PubMed ID: 2572435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative transporter-mediated release from cytoplasmic and vesicular 5-hydroxytryptamine stores in cultured neurons.
    Gu XF; Azmitia EC
    Eur J Pharmacol; 1993 Apr; 235(1):51-7. PubMed ID: 8100196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3,4-Methylenedioxymethamphetamine-induced release of serotonin and inhibition of dorsal raphe cell firing: potentiation by L-tryptophan.
    Sprouse JS; Bradberry CW; Roth RH; Aghajanian GK
    Eur J Pharmacol; 1990 Mar; 178(3):313-20. PubMed ID: 1971220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine.
    Berger UV; Gu XF; Azmitia EC
    Eur J Pharmacol; 1992 May; 215(2-3):153-60. PubMed ID: 1356787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of serotonin induced by 3,4-methylenedioxymethamphetamine (MDMA) and other substituted amphetamines in cultured fetal raphe neurons: further evidence for calcium-independent mechanisms of release.
    Wichems CH; Hollingsworth CK; Bennett BA
    Brain Res; 1995 Oct; 695(1):10-8. PubMed ID: 8574641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine.
    Nash JF; Meltzer HY; Gudelsky GA
    J Pharmacol Exp Ther; 1988 Jun; 245(3):873-9. PubMed ID: 2898523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats.
    Callaway CW; Wing LL; Geyer MA
    J Pharmacol Exp Ther; 1990 Aug; 254(2):456-64. PubMed ID: 1974635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the translocation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA/ecstasy) in synaptosomes: evidence for a presynaptic localization involving the serotonin transporter (SERT).
    Kramer HK; Poblete JC; Azmitia EC
    Neuropsychopharmacology; 1998 Oct; 19(4):265-77. PubMed ID: 9718590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents.
    Hekmatpanah CR; Peroutka SJ
    Eur J Pharmacol; 1990 Feb; 177(1-2):95-8. PubMed ID: 1971219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of 3,4-methylenedioxymethamphetamine on 3,4-dihydroxyphenylalanine accumulation in the striatum and nucleus accumbens.
    Nash JF; Meltzer HY; Gudelsky GA
    J Neurochem; 1990 Mar; 54(3):1062-7. PubMed ID: 1689375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dopamine release: effect of dopamine uptake inhibitors.
    Nash JF; Brodkin J
    J Pharmacol Exp Ther; 1991 Nov; 259(2):820-5. PubMed ID: 1682486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphetamine derivatives induce locomotor hyperactivity by acting as indirect serotonin agonists.
    Callaway CW; Johnson MP; Gold LH; Nichols DE; Geyer MA
    Psychopharmacology (Berl); 1991; 104(3):293-301. PubMed ID: 1924637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity.
    O'Hearn E; Battaglia G; De Souza EB; Kuhar MJ; Molliver ME
    J Neurosci; 1988 Aug; 8(8):2788-803. PubMed ID: 2457659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin1B receptor activation mimics behavioral effects of presynaptic serotonin release.
    Rempel NL; Callaway CW; Geyer MA
    Neuropsychopharmacology; 1993 May; 8(3):201-11. PubMed ID: 8099482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 3,4-methylenedioxymethamphetamine on [3H]paroxetine binding in the frontal cortex and blood platelets of rats.
    Nash JF; Arora RC; Schreiber MA; Meltzer HY
    Biochem Pharmacol; 1991 Jan; 41(1):79-84. PubMed ID: 1702633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral effects of (+-) 3,4-methylenedioxyamphetamine (MDA) and (+-) 3,4-methylenedioxymethamphetamine (MDMA) in the pigeon: interactions with noradrenergic and serotonergic systems.
    Nader MA; Hoffmann SM; Barrett JE
    Psychopharmacology (Berl); 1989; 98(2):183-8. PubMed ID: 2569215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmentation of serotonin release by sustained exposure to MDMA and methamphetamine in rat organotypic mesencephalic slice cultures containing raphe serotonergic neurons.
    Higuchi M; Suzuki Y; Yatani Y; Kitagawa Y; Nagayasu K; Shirakawa H; Nakagawa T; Kaneko S
    J Neurochem; 2008 Sep; 106(6):2410-20. PubMed ID: 18662325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats.
    Mokler DJ; Robinson SE; Rosecrans JA
    Eur J Pharmacol; 1987 Jun; 138(2):265-8. PubMed ID: 2887440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroanatomic specificity and time course of alterations in rat brain serotonergic pathways induced by MDMA (3,4-methylenedioxymethamphetamine): assessment using quantitative autoradiography.
    Battaglia G; Sharkey J; Kuhar MJ; de Souza EB
    Synapse; 1991 Aug; 8(4):249-60. PubMed ID: 1681594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.